Published in Am J Kidney Dis on March 17, 2015
Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors. Hypertension (2016) 0.83
Abnormalities in biomarkers of mineral and bone metabolism in kidney donors. Kidney Int (2016) 0.82
Understanding and Communicating Medical Risks for Living Kidney Donors: A Matter of Perspective. J Am Soc Nephrol (2016) 0.78
Safety of living kidney donation: another brick in the wall…and a solid (physiologic) one. Am J Kidney Dis (2015) 0.75
GFR Evaluation in Living Kidney Donor Candidates. J Am Soc Nephrol (2017) 0.75
Glomerular Function and Structure in Living Donors: Lessons from Single Nephron Studies. Curr Transplant Rep (2016) 0.75
Summary of Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation (2017) 0.75
Concerns about the long-term safety of live kidney donors are justified. Eur J Epidemiol (2017) 0.75
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet (2010) 18.36
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Uric acid and cardiovascular risk. N Engl J Med (2008) 12.20
Long-term consequences of kidney donation. N Engl J Med (2009) 10.17
Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc (1985) 7.02
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48
Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int (2011) 6.01
Proteinuria and reduced kidney function in living kidney donors: A systematic review, meta-analysis, and meta-regression. Kidney Int (2006) 4.41
Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med (2006) 4.32
Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med (2009) 4.05
Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60
The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol (1976) 3.51
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2010) 2.94
Association between serum uric acid and development of type 2 diabetes. Diabetes Care (2009) 2.49
Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44
Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res (2001) 2.35
Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation (2004) 2.22
Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2011) 2.14
Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum (2009) 2.07
Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation (2008) 1.83
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int (1998) 1.77
A prospective controlled study of kidney donors: baseline and 6-month follow-up. Am J Kidney Dis (2013) 1.55
Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center. Am J Transplant (2005) 1.47
Predictors of new-onset decline in kidney function in a general middle-european population. Nephrol Dial Transplant (2007) 1.29
Insulin resistance and hyperinsulinaemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia (1995) 1.07
Prescription medication use among normal weight, overweight, and obese adults, United States, 2005-2008. Ann Epidemiol (2011) 1.03
Renal function before and after unilateral nephrectomy in renal donors. Kidney Int (1975) 1.03
Medical outcomes in African American live kidney donors: a matched cohort study. Am J Transplant (2012) 1.02
Effect of hyperinsulinemia on renal function in a general Japanese population: the Hisayama study. Kidney Int (1999) 0.99
Long-term follow-up of kidney donors: a longitudinal study. Nephrol Dial Transplant (1997) 0.99
Risks and complications in 160 living kidney donors who underwent nephroureterectomy. Nephrol Dial Transplant (2003) 0.98
Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation. Am J Kidney Dis (2011) 0.97
Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study. Nephrol Dial Transplant (2011) 0.97
Do biochemical measures change in living kidney donors? A systematic review. Nephron Clin Pract (2007) 0.96
Fibroblast growth factor-23 and mineral metabolism after unilateral nephrectomy. Nephrol Dial Transplant (2010) 0.93
Insulin resistance in adult polycystic kidney disease. Kidney Int (1997) 0.93
A prospective observational study of changes in renal function and cardiovascular risk following living kidney donation. Transplantation (2008) 0.88
Effects of preexistent hypertension on blood pressure and residual renal function after donor nephrectomy. Transplantation (2012) 0.87
Mild renal dysfunction is associated with insulin resistance in chronic glomerulonephritis. Clin Nephrol (2000) 0.86
Plasma homocysteine levels in living kidney donors before and after uninephrectomy. J Lab Clin Med (2004) 0.84
Circadian blood pressure rhythm is disturbed by nephrectomy. Hypertens Res (2005) 0.84
The prevalence of insulin resistance in kidney disease patients before the development of renal failure. Nephron (1995) 0.82
Serum concentration of vitamin D and parathyroid hormone after living kidney donation. Transplant Proc (2009) 0.82
Uremic toxin development in living kidney donors: a longitudinal study. Transplantation (2014) 0.82
The effect of uninephrectomy on mineral metabolism in normal human kidney donors. Am J Kidney Dis (1988) 0.80
Twenty four-hour ambulatory blood pressure profiles 12 months post living kidney donation. Transpl Int (2010) 0.79
Renal function after nephrectomy in renal donors. Tokai J Exp Clin Med (1982) 0.79
Long-term follow-up of renal donors. Transplant Proc (1998) 0.78
Serum erythropoietin levels in kidney donors after renal transplantation. Transplantation (2000) 0.78
Long-term renal, endocrine, and hematologic evaluation of kidney donors. Transplant Proc (1989) 0.77
Assessment of long-term risks for living related kidney donors by 24-h blood pressure monitoring and testing for microalbuminuria. Clin Transplant (1997) 0.77